-+ 0.00%
-+ 0.00%
-+ 0.00%

Ono Pharmaceutical has entered into an exclusive license agreement with a US biopharmaceutical company for a new drug candidate in Japan and ASEAN countries.

NIKKEI QUICK·10/08/2026 09:21:04

Please log in to view news